NeuroMetrix, Inc. Launches Quell® App for Apple Watch®, the First Smartwatch App for an Over-The-Counter Pain Relief Device
September 22, 2020 at 07:00 am EDT
Share
NeuroMetrix, Inc. reported the launch of the Quell Watch App, available for download from the Apple App store. Quell is a wearable, transcutaneous electrical nerve stimulation (TENS) device for knee, foot and leg pain that is available over-the-counter. It can be used during the day while active and at night while sleeping. Users can personalize and manage therapy discreetly via the mobile app for iPhone and Android smartphones. Quell is also a pain management solution with pain, sleep, activity and gait tracking. The Quell Health Cloud® provides customized feedback and powers one of the large chronic pain outcomes databases. Like Quell, a smartwatch is always on the body. This enables a high level of integration and novel pain relief functionality. It is for this reason that the company developed the Quell Watch app, the first and only TENS smartwatch app. The Quell Watch app was designed to leverage the unique features of the Apple Watch. The Quell Watch app is standalone, so it functions independently of the iPhone. It gives a Quell user the ability to control the device and monitor pain relief from the wrist; a level of convenience never before achieved with a TENS device. The user simply taps the Quell complication to open the app. The user can then easily start or stop therapy, increase or decrease intensity, view their therapy schedule, and get Quell status information. The battery level can be checked by just glancing at the complication. A particularly valuable feature of the Quell Watch app is notifications. The app is in regular, behind the scenes, communication with Quell. This enables alerts such as when the Quell battery is low or if therapy unexpectedly halted. These notifications help ensure that the user does not miss out on pain relief. The notifications are configurable so the Quell Watch app experience can be personalized.
NeuroMetrix, Inc. is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The Company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The Company has two commercial brands. Quell is a wearable neuromodulation platform. DPNCheck is a point-of-care screening test for peripheral neuropathy. It operates two product categories: Diagnostic technology and Therapeutic technology. Diagnostic technology product category is engaged in point-of-care peripheral neuropathy assessment. Therapeutic technology product category is engaged in wearable neuromodulation for chronic pain syndromes. Its patients control and personalize the technology via a mobile phone application, and their utilization and certain clinical metrics may be tracked in the Quell Health Cloud.